SecBot SecBot
Insider Cluster (5 insiders) ·Filed May 22, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago
Insider cluster: 5 insiders, $1.1M total
Actionable Insight • Neutral

The insider sales are routine post-offering liquidity events, no bearish signal. Monitor the upcoming Phase 3 data readout for deucrictibant (expected H2 2026) as the primary catalyst. The $107.5M raise provides runway into H1 2028, reducing near-term financing risk.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$29.68
T+0 close · May 22, 2026 · via day close
Latest settled
+21.63%
T+60 · $36.10
Vs SPY
+18.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 22 $29.68entry
  2. T+1 · 6mo ago +0.67%α +0.09% · $29.88
  3. T+5 · 6mo ago −1.95%α −3.63% · $29.10
  4. T+20 · 5mo ago +9.47%α +10.88% · $32.49
  5. T+60 · 3mo ago +21.63%α +18.44% · $36.10
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five Pharvaris insiders, including the CEO and CCO, sold a total of ~$1.08M in open-market sales over a 7-day window, following a $107.5M equity offering that closed 14 days prior. The sales represent ~0.05% of the $2.1B market cap, a trivial amount, and are likely liquidity-driven after the offering's lock-up expiration rather than a bearish signal on the pipeline.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
5

Key Facts

  • Five insiders sold a combined ~36,300 shares for ~$1.08M in open-market transactions (May 13-20, 2026).
  • CEO Berndt Modig sold 2,292 shares for ~$67K; CCO Wim Souverijns sold 10,000 shares for ~$299K.
  • Total sales equal ~0.05% of Pharvaris' $2.1B market cap, well below the 0.1% materiality threshold.
  • The cluster follows a $107.5M underwritten public offering (424B5, May 8, 2026) that extended cash runway into H1 2028.
  • Director Elisabeth Bjork also exercised 10,000 options at $8.05/share ($80,500 cost) and sold the shares for $293K, a net cash-out of ~$213K.

Financial Impact

Total insider sales of ~$1.08M, or 0.05% of market cap, immaterial relative to company size.

dilution

Risk Factors

  • Phase 3 clinical trial failure for deucrictibant in HAE would be a material negative catalyst.
  • Further insider selling at higher volumes (>0.5% of market cap) could signal loss of confidence.
  • Cash burn rate may accelerate if US commercialization costs ramp faster than expected.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1779476076663

Track record

51 reports on PHVS

Performance horizon

15 of 18 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 19 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
  3. Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  4. Nov 12, 20264d ago 6-K Neutral 4/10 No price data
  5. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  6. Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
  7. Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  8. Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  9. Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
  10. Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
Showing 10 of 51

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026